Fuentes-Fayos, A.C.; G-GarcÃa, M.E.; Pérez-Gómez, J.M.; Peel, A.; Blanco-Acevedo, C.; Solivera, J.; Ibáñez-Costa, A.; Gahete, M.D.; Castaño, J.P.; Luque, R.M.
Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance. Int. J. Mol. Sci. 2022, 23, 1143.
https://doi.org/10.3390/ijms23031143
AMA Style
Fuentes-Fayos AC, G-GarcÃa ME, Pérez-Gómez JM, Peel A, Blanco-Acevedo C, Solivera J, Ibáñez-Costa A, Gahete MD, Castaño JP, Luque RM.
Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance. International Journal of Molecular Sciences. 2022; 23(3):1143.
https://doi.org/10.3390/ijms23031143
Chicago/Turabian Style
Fuentes-Fayos, Antonio C., Miguel E. G-GarcÃa, Jesús M. Pérez-Gómez, Annabel Peel, Cristóbal Blanco-Acevedo, Juan Solivera, Alejandro Ibáñez-Costa, Manuel D. Gahete, Justo P. Castaño, and Raúl M. Luque.
2022. "Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance" International Journal of Molecular Sciences 23, no. 3: 1143.
https://doi.org/10.3390/ijms23031143
APA Style
Fuentes-Fayos, A. C., G-GarcÃa, M. E., Pérez-Gómez, J. M., Peel, A., Blanco-Acevedo, C., Solivera, J., Ibáñez-Costa, A., Gahete, M. D., Castaño, J. P., & Luque, R. M.
(2022). Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance. International Journal of Molecular Sciences, 23(3), 1143.
https://doi.org/10.3390/ijms23031143
